SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-22-000596
Filing Date
2022-02-14
Accepted
2022-02-14 06:13:54
Documents
2
Group Members
SPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LPSPHERA HEALTHCARE US INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2227289.htm SC 13G/A 122211
2 EXHIBIT 1 exhibit_1.htm EX-99 5562
  Complete submission text file 0001178913-22-000596.txt   129564
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80900 | Film No.: 22624619
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A